Understanding The Role of CYP4F62P in Drug Metabolism (G646802)

Target Name: CYP4F62P

NCBI ID: G646802

CYP4F62P

Other Name(s): CYP4F43P | cytochrome P450 family 4 subfamily F member 62, pseudogene | Cytochrome P450 family 4 subfamily F member 62, pseudogene

Understanding The Role of CYP4F62P in Drug Metabolism

CYP4F62P, also known as CYP4F43P, is a protein that is expressed in various tissues throughout the body. It is a member of the CYP family, which is a family of enzymes that are involved in the metabolism of a wide variety of drugs. CYP4F62P is specifically involved in the metabolism of several drugs, including many statins, which are used to treat high cholesterol.

One of the main functions of CYP4F62P is to metabolize statins. Statins are a common type of drug that is used to lower cholesterol levels in the blood. These drugs work by inhibiting the production of cholesterol in the liver, which in turn helps to reduce the amount of harmful low-density lipoprotein (LDL) cholesterol in the blood. By reducing the level of LDL cholesterol, statins can help to prevent the development of heart disease and stroke, which are two of the leading causes of death and disability in the world.

CYP4F62P is also involved in the metabolism of other drugs that are used to treat a wide range of conditions. For example, it is often used to metabolize antidepressants, which are used to treat depression and other mood disorders. Additionally, CYP4F62P is also involved in the metabolism of blood thinners, which are used to prevent blood clots.

Despite its many important functions, CYP4F62P is not yet widely understood. Many scientists believe that it may be a drug target, or a biomarker, that can be targeted by drug developers. This is because CYP4F62P is involved in the metabolism of many different drugs, and drugs that are used to treat a wide range of conditions may be able to interfere with its function. Additionally, because CYP4F62P is expressed in many different tissues throughout the body, it is difficult to study its effects in a controlled way.

In conclusion, CYP4F62P is a protein that is involved in the metabolism of a wide variety of drugs. It is a member of the CYP family and is specifically involved in the metabolism of statins, antidepressants, and blood thinners. While it is not yet widely understood, many scientists believe that it may be a drug target or biomarker that can be targeted by drug developers. Further research is needed to fully understand its functions and potential applications.

Protein Name: Cytochrome P450 Family 4 Subfamily F Member 62, Pseudogene

The "CYP4F62P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP4F62P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets